Pancreaticoduodenectomy without pancreaticojejunostomy in a patient with near-complete fatty replacement of the distal pancreas: a surgical technique.
- 1Department of Hepatobiliary and Pancreatic Surgery, Baoding Sixth Hospital, Baoding, China.
Abstract
Pancreaticojejunostomy after pancreaticoduodenectomy presupposes a viable distal pancreatic remnant with a drainable ductal system. We report a 68-year-old woman in whom this prerequisite was absent because the pancreatic body and tail were almost completely replaced by fat. The pancreatic-head cystic lesion was discovered incidentally during evaluation of an L3 compression fracture. She had no abdominal symptoms or jaundice. Computed tomography (CT) and magnetic resonance imaging/magnetic resonance cholangiopancreatography (MRI/MRCP) showed a 5.9-6.1 cm well-circumscribed, septated honeycomb lesion in the pancreatic head, favoring a microcystic serous cystic neoplasm (SCN), without biliary or main pancreatic duct dilatation; the body and tail were not recognizable as continuous pancreatic parenchyma and appeared to be replaced by fat. Because a mucinous cystic neoplasm could not be excluded with sufficient confidence, the patient chose resection after counselling. At open pancreaticoduodenectomy, the expected distal pancreatic region consisted of adipose tissue without recognizable gland. After pancreatic-neck transection, direct inspection identified neither a pancreatic duct nor visible pancreatic juice, and no suitable parenchyma was available for anastomosis. Pancreaticojejunostomy was therefore not performed, and the transection surface was closed directly. Permanent pathology confirmed microcystic serous cystadenoma with negative margins. No clinically apparent pancreatic fistula or intra-abdominal collection requiring intervention was documented; postoperative calf deep-vein thromboses and supraventricular tachycardia were treated. At approximately 6 months, CT showed no recurrent mass. Systematic glycated hemoglobin (HbA1c), insulin requirement, steatorrhea, pancreatic enzyme replacement, and other formal endocrine/exocrine outcomes were not available, precluding conclusions about long-term functional safety. The report illustrates an individualized reconstructive decision applicable only when viable distal pancreatic parenchyma and a meaningful ductal target are genuinely absent.
Related
- Spiral Jejunal Reconstruction of Both Pancreatic Stumps in Type II Portal Annular Pancreas during Pancreaticoduodenectomy: A Case Report
- Intraoperative failure in valve-sparing aortic root replacement: technique, experience, and the definition of success.
- A novel variant of pancreaticobiliary maljunction: Complete opening of the common bile duct into the duct of Santorini in a patient with pancreas divisum.
- INNOVATIVE RECANALIZATION TECHNIQUE USING DIATHERMIC PUNCTURE UNDER COLANGIOSCOPY FOR COMPLETE BILIARY STRICTURE.
- Modified abdominal advancement flap with or without the Ochikomanai method: Oncoplastic surgery using a simple volume replacement technique
BibTeX
@article{li2026pancreaticoduodenectomy,
title = {{Pancreaticoduodenectomy without pancreaticojejunostomy in a patient with near-complete fatty replacement of the distal pancreas: a surgical technique.}},
author = {Xiaojun Li and Jun Zhang and Xiaowei Li and Pengfei Xu and Liuman Yang and Cong Shao and Dan Su},
journal = {Gland surgery},
year = {2026},
month = sep,
doi = {10.21037/gs-2026-0407},
url = {https://europepmc.org/article/MED/42996829},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Pancreaticoduodenectomy without pancreaticojejunostomy in a patient with near-complete fatty replacement of the distal pancreas: a surgical technique.
AU - Xiaojun Li
AU - Jun Zhang
AU - Xiaowei Li
AU - Pengfei Xu
AU - Liuman Yang
AU - Cong Shao
AU - Dan Su
PY - 2026
DA - 2026/09/30
JO - Gland surgery
DO - 10.21037/gs-2026-0407
UR - https://europepmc.org/article/MED/42996829
AB - Pancreaticojejunostomy after pancreaticoduodenectomy presupposes a viable distal pancreatic remnant with a drainable ductal system. We report a 68-year-old woman in whom this prerequisite was absent because the pancreatic body and tail were almost completely replaced by fat. The pancreatic-head cystic lesion was discovered incidentally during evaluation of an L3 compression fracture. She had no abdominal symptoms or jaundice. Computed tomography (CT) and magnetic resonance imaging/magnetic resonance cholangiopancreatography (MRI/MRCP) showed a 5.9-6.1 cm well-circumscribed, septated honeycomb lesion in the pancreatic head, favoring a microcystic serous cystic neoplasm (SCN), without biliary or main pancreatic duct dilatation; the body and tail were not recognizable as continuous pancreatic parenchyma and appeared to be replaced by fat. Because a mucinous cystic neoplasm could not be excluded with sufficient confidence, the patient chose resection after counselling. At open pancreaticoduodenectomy, the expected distal pancreatic region consisted of adipose tissue without recognizable gland. After pancreatic-neck transection, direct inspection identified neither a pancreatic duct nor visible pancreatic juice, and no suitable parenchyma was available for anastomosis. Pancreaticojejunostomy was therefore not performed, and the transection surface was closed directly. Permanent pathology confirmed microcystic serous cystadenoma with negative margins. No clinically apparent pancreatic fistula or intra-abdominal collection requiring intervention was documented; postoperative calf deep-vein thromboses and supraventricular tachycardia were treated. At approximately 6 months, CT showed no recurrent mass. Systematic glycated hemoglobin (HbA1c), insulin requirement, steatorrhea, pancreatic enzyme replacement, and other formal endocrine/exocrine outcomes were not available, precluding conclusions about long-term functional safety. The report illustrates an individualized reconstructive decision applicable only when viable distal pancreatic parenchyma and a meaningful ductal target are genuinely absent.
SN - 2227-684X
SN - 2227-8575
ER -